IL6 and obesity disorder: In this way, obesity and mitochondrial dysfunction dysregulate the production of WAT-derived circulating adipokines such as interleukins (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α, which may exacerbate the state of low-grade, chronic inflammation observed in obesity [14].